Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- ACN +7%, CMC +3.5%, DRI +3%, KBH +2%, SCS +1.7%
Other news:
- TPST +44.9% (to Report New Data from Global Randomized Combination Study of Amezalpat (TPST-1120) in First-Line Hepatocellular Carcinoma)
- HROW +26.5% (provides TRIESENCE relaunch update)
- EVO +10.8% (speaking with advisors as decline in share price prompts talk of takeover, according to Bloomberg)
- ATAI +7.9% (announces update on Beckley Psytech's Phase 1/2a trial of ELE-101 )
- SLN +7.1% (Topline 48-Week Data from Phase 2 Study of Zerlasiran in Patients with Elevated Lipoprotein)
- VUZI +6.8% (Vuzix and Avegant Announce Strategic Partnership to Develop Optimized Optical Modules for AI-Enabled Smart Glasses)
- VZLA +4% (Announces Receipt of Court Approval and Expected Closing Date for Vizsla Royalties Spinout)
- OPT +3.2% (A$55.0 mln ($36.9 mln) Retail Entitlement Offer Opens)
- GYRE +2.9% (announces publication in Journal of Gastroenterology)
- DELL +2.9% (Elon Musk says "To be precise, Dell is assembling half of the racks that are going into the supercomputer that xAI is building" )
- MNMD +2.7% (Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder)
- TREE +2.3% (names new CFO, also raises Q2 revenue guidance)
- PHG +1.9% (completes cancellation of 4.4 million shares)
- BTG +1.9% (announces positive preliminary economic assessment results for the Gramalote Project; after-tax NPV (5%) of $778 million with an after-tax IRR of 20.6%) LXRX +1.7% (Data From Lexicon's RELIEF-DPN 1 Phase 2 Study of LX9211 Published Today in Diabetes Care, a Peer-Reviewed Journal of the American Diabetes Association)
- VOD +1.7% (sells 18.0% stake in Indus Towers)
- PLTR +1.7% (has been selected by the Advanced Research Projects Agency for Health (ARPA-H) to support the agency's mission to accelerate better health outcomes) LNZA +1.6% (increases share ownership of LanzaJet )
- SNX +1.5% (CRSR and SNX announce new partnership)
- BG +1.5% (announces sale of its ownership share in its sugar and bioenergy joint venture in Brazil)
- ALDX +1.4% (Announces Advancement of New RASP Modulators and Recent Preclinical Data in Obesity at 2024 Investor Roundtable)
- PLL +1.3% (announced that additional high-grade drill results at North American Lithium in Quebec continue to demonstrate the potential for a significant upgrade to the mineral resource estimate)
- PBR +1.2% (provides information about FPSO Maria Quitéria; signs Protocol of Intentions with the Government of Rio de Janeiro)
- VALE +1.1% (provides update on Salobo 3 plant operations)
- GXO +1.1% (conducting an early-stage proof-of-concept program in partnership with robot manufacturer Apptronik)